BRAVO (BIG 5-13)
Intro text:
Page under construction!
Niraparib for patients with HER2-negative, germline BRCA mutation-positive breast cancer
- ClinicalTrials.gov Identifier: NCT01905592
Niraparib for patients with HER2-negative, germline BRCA mutation-positive breast cancer